Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00147901
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
German CLL Study Group 61
Early research (Phase 1)Study completedNCT00545519
What this trial is testing

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Relapsed Or Refractory Multiple Myeloma
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT05115630
What this trial is testing

Off-the-shelf NK Cells + SCT for Myeloid Malignancies

Who this might be right for
Myeloid MalignanciesAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 24
Post-approval studies (Phase 4)Looking for participantsNCT07604311
What this trial is testing

Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Nanfang Hospital, Southern Medical University 288
Not applicableStudy completedNCT05990699
What this trial is testing

Effect of Mindfulness-Based Relapse Prevention Program on Readiness for Change and Self-efficacy Among Clients With Substance Use Disorders

Who this might be right for
Substance Use Disorders
Alexandria University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07670312
What this trial is testing

Evaluation of XYA02 in Patients With Advanced Solid Tumors

Who this might be right for
MUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
XYone Therapeutics, Inc 190
Not applicableEnded earlyNCT04102475
What this trial is testing

Efficacy of a Phone-based Relapse Prevention for Anorexia Nervosa After a First Hospitalization

Who this might be right for
Anorexia Nervosa
University Hospital, Lille 19
Not applicableStudy completedNCT00744601
What this trial is testing

Impulsivity, Neural Deficits and Cocaine Addiction

Who this might be right for
Cocaine Dependence
University of Texas Southwestern Medical Center 90
Early research (Phase 1)Ended earlyNCT00022971
What this trial is testing

Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Testing effectiveness (Phase 2)Study completedNCT00006364
What this trial is testing

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00025363
What this trial is testing

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

Who this might be right for
Alveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma+2 more
National Cancer Institute (NCI) 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03989414
What this trial is testing

Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Celgene 424
Testing effectiveness (Phase 2)WithdrawnNCT06351306
What this trial is testing

DEC-C and Thioguanine for R/R AML

Who this might be right for
Acute Myeloid Leukemia
Columbia University
Testing effectiveness (Phase 2)UnknownNCT00002532
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Hannover Medical School
Large-scale testing (Phase 3)Study completedNCT00005863
What this trial is testing

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Medical Research Council
Large-scale testing (Phase 3)Study completedNCT01910987
What this trial is testing

Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 80
Testing effectiveness (Phase 2)UnknownNCT04674514
What this trial is testing

APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ascentage Pharma Group Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02247349
What this trial is testing

BMS-986012 in Relapsed/Refractory SCLC

Who this might be right for
Small Cell Lung Cancer
Bristol-Myers Squibb 106
Next Page